Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Vigil Neuroscience Launches No-Cost Genetic Counseling, Testing Program for Rare Neurologic Disorder
The firm is partnering with InformedDNA and PreventionGenetics to improve diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
The test showed good accuracy for detecting the disease while also distinguishing different subtypes, suggesting it could help guide treatment in the future.
Firms including Roche and Quest have moved into the space, providing both a vote of confidence and new competition for smaller players that pioneered it.
CND Life Sciences Closes $4.5M Series Seed 3 Financing Round
The company will use the funding to accelerate commercialization of its Syn-One test for identifying abnormal alpha-synuclein aggregation via skin biopsy.
PanGenomic Health Subsidiary MUJN Diagnostics Partners With Hemex on Brain Health Dx
The companies aim to develop tests for use with alternative brain health therapies that run on Hemex Health's Gazelle point-of-care instrument.